Evidence map›Paper›PMID 27588130›Full record

ArticleOncology letters2016

Valproic acid induces autophagy by suppressing the Akt/mTOR pathway in human prostate cancer cells.

Qinghua Xia, Yi Zheng, Wei Jiang, Zhongxian Huang, Muwen Wang, Ronald Rodriguez, Xunbo Jin

Open access · diamondAbstract read
In one paragraph

Article in Oncology letters, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Beyond epilepsy: The expanding role of valproic acid in Alzheimer disease therapy - a review.The Journal of pharmacology and experimental therapeutics · 2025
    Review
  3. Article
  4. Article
  5. Review
  6. Combination of multivalent DR5 receptor clustering agonists and histone deacetylase inhibitors for treatment of colon cancer.Journal of controlled release : official journal of the Controlled Release Society · 2024
    Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. All-Frontiers in oncology · 2022
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. mTOR-Related Cell-Clearing Systems in Epileptic Seizures, an Update.International journal of molecular sciences · 2020
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Qinghua XiaDepartment of Minimally Invasive Urology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, P.R. China.
Yi ZhengDepartment of Emergency, Qilu Hospital of Shandong University, Jinan, Shandong 250012, P.R. China.
Wei JiangDepartment of Minimally Invasive Urology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, P.R. China.
Zhongxian HuangDepartment of Urology, University of Texas Health Science Center, San Antonio, TX 78229-3900, USA.
Muwen WangDepartment of Minimally Invasive Urology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, P.R. China.
Ronald RodriguezDepartment of Urology, University of Texas Health Science Center, San Antonio, TX 78229-3900, USA.
Xunbo JinDepartment of Minimally Invasive Urology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, P.R. China.
Shandong Provincial Hospital · CNThe University of Texas Health Science Center at San Antonio · USQilu Hospital of Shandong University · CNShandong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previous studies have demonstrated that the chronic administration of valproic acid (VPA) suppresses angiogenesis

Indexed as

Akt/mammalian target of rapamycin pathwayautophagyhistone deacetylase inhibitorprostate cancervalproic acid

Identifiers

PMID27588130
PMCPMC4998110
OpenAlexW2487765256

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.